CHRS CHRS R2K
$1.59
+104.11% 1Y
Market & Price
Market Cap
-
Current Price
$1.59
High / Low (52W)
$2.51 / $0.72
Beta
-
Valuation
Stock P/E
-
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
-
Profitability & Returns
ROCE
-149.50%
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
EPS (Latest Qtr)
$-0.28
EPS (TTM)
$-
Balance Sheet & Liquidity
Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$258.34M
Current Assets
$206.71M
Working Capital
$64.83M
Ownership
Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
-
Total Revenue (TTM)
-
EBITDA
-
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Growth (CAGR)
Revenue 5Y
-41.54%
Profit 5Y
52.53%
Revenue (YoY)
-
Earnings (YoY)
-
PROS
- Profit CAGR of 52.5% over 5 years.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -41.5% CAGR over 5 years.
- Trading 36.6% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Ad space
Quarterly Results
Figures in USD.
| Metric | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | 161.00K | 1.40M | 0 | 0 | 0 | 0 | 0 | 0 | 37.10M | 83.43M | 111.68M | 123.86M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7.60M | 10.25M | 11.57M | 12.75M | 12.31M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.65M | 3.40M | 3.72M | 4.04M | 3.81M |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 34.87M | 82.83M | 105.24M | 116.05M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.95M | 6.86M | 7.85M | 8.70M | 8.50M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 50.38M | 52.34M | 52.18M | 54.58M | 44.65M |
| Operating Income | -58.90M | -71.22M | - | -64.35M | -62.74M | 84.62M | - | -72.42M | -56.64M | -56.62M | - | -42.03M | -44.91M | -56.97M | - | -16.60M | 27.49M | 51.84M | - | 40.87M | 65.31M | 33.72M | -167.36M | -24.16M | -32.79M | -80.92M | -44.01M | -80.45M | -67.75M | -34.54M | -32.01M | -67.79M | -39.63M | - | - | -45.44M | -45.49M | -44.33M | -45.88M | -36.15M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -44.20M | -41.57M | -41.23M | -43.20M | -33.87M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.15M | 2.28M | 2.33M | 2.25M | 2.19M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -47.40M | -44.86M | -44.52M | -46.35M | -36.94M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Net Income | -58.81M | -71.33M | -52.39M | -65.39M | -69.97M | 83.94M | -75.92M | -74.78M | -55.34M | -58.99M | -49.07M | -44.30M | -43.64M | -58.81M | -62.60M | -20.00M | 23.57M | 47.04M | - | 35.57M | 59.03M | 27.93M | -172.95M | -29.90M | -38.53M | -96.08M | -50.15M | -86.65M | -75.73M | -42.87M | -39.64M | 102.88M | -12.92M | - | - | -56.57M | 297.77M | -35.53M | -37.64M | -38.33M |
| Diluted EPS | - | -1.86 | - | -1.67 | -1.72 | 1.67 | -1.71 | - | - | -1.09 | - | - | -0.68 | -0.87 | - | -0.29 | 0.32 | 0.63 | 0.53 | 0.48 | 0.70 | 0.33 | -2.37 | -0.40 | -0.49 | -1.24 | -0.65 | -1.11 | -0.96 | -0.49 | -0.41 | 0.91 | -0.11 | - | - | -0.49 | 2.57 | -0.31 | -0.31 | -0.28 |
| R&D Expense | 56.94M | 68.22M | - | 65.31M | 65.54M | 64.57M | - | 53.77M | 34.50M | 42.63M | - | 25.45M | 26.52M | 31.60M | - | 18.79M | 18.88M | 21.57M | - | 33.11M | 26.17M | 38.85M | 203.49M | 54.77M | 54.09M | 82.92M | 41.61M | 45.81M | 34.15M | 23.27M | 25.65M | 28.42M | 20.60M | 22.05M | - | 24.36M | 26.31M | 27.25M | - | 21.54M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 189.48M | 1.56M | 0 | - | - | - | 211.04M | 257.24M | 26.39M | 42.17M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | 70.08M | 158.99M | 8.73M | 13.81M |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | 140.96M | 98.25M | 17.66M | 28.36M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | 397.84M | 301.45M | 217.31M | 209.49M |
| Operating Income | -38.52M | -35.99M | -64.68M | -219.07M | -115.93M | -232.14M | -204.42M | 107.77M | 156.32M | - | -256.88M | -203.20M | -199.65M | -181.13M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | -255.58M | -193.94M | -199.38M | -170.20M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | 32.47M | 40.54M | 10.73M | 9.00M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | -291.75M | -238.27M | -215.39M | -183.12M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | 0 | -380.00K | 0 | 0 |
| Net Income | -33.02M | -53.63M | -87.13M | -223.26M | -127.34M | -238.17M | -209.34M | 89.83M | 132.24M | - | -291.75M | -237.89M | 28.51M | 168.02M |
| Diluted EPS | - | - | - | - | - | -4.48 | -3.22 | 1.23 | 1.62 | -3.81 | -3.76 | -2.53 | 0.25 | - |
| R&D Expense | 34.89M | 31.28M | 78.22M | 213.06M | 254.44M | 162.39M | 110.24M | 94.19M | 142.76M | 363.11M | 199.36M | 109.44M | 91.83M | 108.89M |
Compounded Sales Growth
| 5 Years: | -41.54% |
| 1 Year: | - |
Compounded Profit Growth
| 5 Years: | 52.53% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +104.11% |
| 6 Months: | +24.22% |
| 3 Months: | -4.79% |
| 1 Month: | -8.62% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 47.45M | 187.22M | 212.38M | 178.49M | 162.61M | 99.47M | 408.93M | 841.65M | - | 480.85M | 629.60M | 448.53M | 258.34M |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | 381.23M | 475.63M | 341.58M | 206.71M |
| Cash & Equivalents | 7.68M | 14.55M | 39.55M | 150.39M | 158.23M | 124.95M | 126.91M | 72.36M | 177.67M | 541.16M | - | 63.55M | 102.89M | 125.99M | 88.88M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | 38.79M | 62.60M | 4.21M | 3.17M |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | 109.96M | 260.52M | 111.32M | 17.82M |
| Total Liabilities | - | - | 89.83M | 120.46M | 219.31M | 159.13M | 132.08M | 138.06M | 303.71M | 560.67M | - | 618.26M | 823.03M | 580.52M | 197.33M |
| Current Liabilities | - | - | 53.70M | 51.78M | 106.02M | 56.38M | 28.39M | 33.26M | 114.97M | 145.65M | - | 138.69M | 331.77M | 282.98M | 141.88M |
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | 471.06M | 473.37M | 264.93M | 37.05M |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | 480.42M | 480.84M | 269.90M | 40.34M |
| Total Equity | - | - | -97.08M | 66.80M | -6.21M | 20.53M | 30.54M | -38.59M | 105.21M | 280.97M | - | -137.42M | -193.43M | -131.99M | 61.01M |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | 78.85M | 112.22M | 115.61M | 121.15M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | -252.54M | -200.29M | -159.27M | 28.36M | 154.15M | - | -241.12M | -174.88M | -20.44M | -138.51M |
| Investing Cash Flow | - | - | - | - | -6.51M | -4.42M | -1.19M | -12.73M | -14.40M | - | -166.85M | 144.64M | 230.32M | 375.09M |
| Financing Cash Flow | - | - | - | - | 226.18M | 206.79M | 105.42M | 89.37M | 223.95M | - | 54.33M | 69.60M | -186.97M | -273.70M |
| Capital Expenditure | -1.78M | -373.00K | -2.85M | -6.16M | -6.51M | -4.57M | -789.00K | -1.82M | -7.23M | -1.29M | -2.04M | -286.00K | - | - |
| Free Cash Flow | - | - | - | - | -259.06M | -204.86M | -160.06M | 26.53M | 146.91M | - | -241.12M | -174.88M | -20.44M | -138.51M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | -353.65M | 39.36M | 22.91M | -37.13M |
| Share Buybacks | - | - | 2.00K | - | - | - | - | - | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | 66.8% | 38.2% | 66.9% | 67.2% |
| Operating Margin % | - | - | - | - | -61.2% | -14,918.8% | - | - | - | - | -121.7% | -79.0% | -756.6% | -429.5% |
| Net Margin % | - | - | - | - | -67.2% | -15,306.6% | - | - | - | - | -138.2% | -92.5% | 108.0% | 398.4% |
| ROE % | - | 55.2% | -130.4% | 3,596.9% | -620.3% | -780.0% | 542.5% | 85.4% | 47.1% | - | 212.3% | 123.0% | -21.6% | 275.4% |
| ROCE % | - | 575.5% | -47.8% | -206.0% | -94.9% | -173.0% | -308.8% | 36.7% | 22.5% | - | -75.1% | -68.2% | -120.6% | -155.5% |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CHRS
No recent headlines available.